Premium
Agonists induce conformational changes in transmembrane domains III and VI of the β 2 adrenoceptor
Author(s) -
Gether Ulrik,
Lin Sansan,
Ghanouni Pejman,
Ballesteros Juan A.,
Weinstein Harel,
Kobilka Brian K.
Publication year - 1997
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/16.22.6737
Subject(s) - agonist , receptor , transmembrane protein , transmembrane domain , biology , biophysics , conformational change , g protein coupled receptor , binding site , biochemistry
Agonist binding to G protein‐coupled receptors is believed to promote a conformational change that leads to the formation of the active receptor state. However, the character of this conformational change which provides the important link between agonist binding and G protein coupling is not known. Here we report evidence that agonist binding to the β 2 adrenoceptor induces a conformational change around 125 Cys in transmembrane domain (TM) III and around 285 Cys in TM VI. A series of mutant β 2 adrenoceptors with a limited number of cysteines available for chemical derivatization were purified, site‐selectively labeled with the conformationally sensitive, cysteine‐reactive fluorophore IANBD and analyzed by fluorescence spectroscopy. Like the wild‐type receptor, mutant receptors containing 125 Cys and/or 285 Cys showed an agonist‐induced decrease in fluorescence, while no agonist‐induced response was observed in a receptor where these two cysteines were mutated. These data suggest that IANBD bound to 125 Cys and 285 Cys are exposed to a more polar environment upon agonist binding, and indicate that movements of transmembrane segments III and VI are involved in activation of G protein‐coupled receptors.